Sativex is an endocannabinoid system modulator made up principally of two active ingredients -THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol). Sativex, administered as an oral spray, is specifically designed for
iBIO Institute orchestrates business leadership in the service of educational programs and job-creating technology startups. PROPEL helps to guide the development of formation-stage and early-stage life sciences companies
The new patent covers DNA vaccines containing codon-optimized versions of genes encoding gB and CMV phosphoprotein 65 (pp65) antigens, and adds to Vical‘s family of patents in the
Sucanon is one of only three approved drugs for a class of diabetic medications called ‘Insulin Sensitizers’ in the multi-billion dollar market. It lowers a patient’s blood sugar
CogniSure is the sole US dietary supplement that has Colostrinin, the only colostrum-derived, protein-rich polypeptide (PRP) complex shown to influence brain aging mechanisms and to support adult cognitive
Auralgan Otic Solution is a prescription drug used to treat pain and inflammation associated with ear infections. According to the FDA, the sale of Auralgan in the US
SC MabThera has been developed through collaboration between Halozyme and Roche, in which Halozyme has agreed to apply its proprietary Enhanze technology to Roche’s biological therapeutic compounds. MabThera
Fabry’s disease is an inherited lysosomal storage disorder brought about by the deficiency of the alpha-galactosidase A (alpha-Gal A)enzyme. The extension study designed to evaluate the long-term safety
Zymes is engaged in developing a novel, water-soluble, readily applicable patented formulation of nano-micellar complex of CoQ10 and pro-drug form of vitamin E (WS-CoQ10), licensed from the National
NICE’s evaluation took into account peer-reviewed clinical studies that demonstrated VIDAZA as an innovative epigenetic, life-extending, cost-effective therapy for the National Health Service (NHS). Celgene Corporation CEO Robert
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.